Cargando…
Balancing commercial and public interests
A large number of randomized clinical trials with important health outcomes are completed each year. Those with favorable findings are typically reported and published rapidly, while the publication of those with unfavorable results is often delayed or given a positive "spin." This observa...
Autores principales: | Furberg, Curt D, Hall, Mark A, Sevick, Mary Ann |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC479709/ https://www.ncbi.nlm.nih.gov/pubmed/15239846 http://dx.doi.org/10.1186/1468-6708-5-6 |
Ejemplares similares
-
Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data
por: Strech, Daniel, et al.
Publicado: (2012) -
Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007) -
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
por: Furberg, Curt D
Publicado: (2001) -
Withdrawal of cerivastatin from the world market
por: Furberg, Curt D, et al.
Publicado: (2001) -
Ushering in the New Toxicology: Toxicogenomics and the Public Interest
por: Balbus, John M.
Publicado: (2005)